SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services.
SynsoryBio has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2024.
SynsoryBio's investors include Y Combinator, Unpopular Ventures.
SynsoryBio is headquartered in Somerville, United States.
SynsoryBio is a biotechnology research company that offers next-generation protein therapeutics services.
SynsoryBio is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SynsoryBio — Funding & Investors." VCBacked, April 3, 2024, https://www.vcbacked.co/company/synsorybio. Accessed July 20, 2026.
VCBacked. (2024). SynsoryBio — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/synsorybio
{{cite web |title=SynsoryBio — Funding & Investors |url=https://www.vcbacked.co/company/synsorybio |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated